Chronicle Journal: Finance

Ardelyx lowers IPO target slightly, now hopes to raise up to $62M

Biotech company Ardelyx updated its IPO plans on Monday, saying it now hopes to raise up to $62 million...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.